6523

PHC Holdings TSE:6523 Stock Report

Last Price

JP¥1.26k

Market Cap

JP¥157.3b

7D

0.3%

1Y

n/a

Updated

02 Jul, 2022

Data

Company Financials +
6523 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health1/6
Dividends3/6

6523 Stock Overview

PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products.

PHC Holdings Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PHC Holdings
Historical stock prices
Current Share PriceJP¥1,264.00
52 Week HighJP¥3,120.00
52 Week LowJP¥1,193.00
Beta0
1 Month Change-12.71%
3 Month Change-28.51%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-52.32%

Recent News & Updates

Shareholder Returns

6523JP Medical EquipmentJP Market
7D0.3%-1.1%-1.1%
1Yn/a-14.6%-7.0%

Return vs Industry: Insufficient data to determine how 6523 performed against the JP Medical Equipment industry.

Return vs Market: Insufficient data to determine how 6523 performed against the JP Market.

Price Volatility

Is 6523's price volatile compared to industry and market?
6523 volatility
6523 Average Weekly Movement6.0%
Medical Equipment Industry Average Movement4.6%
Market Average Movement4.2%
10% most volatile stocks in JP Market8.4%
10% least volatile stocks in JP Market2.2%

Stable Share Price: 6523 is more volatile than 75% of JP stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 6523's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of JP stocks.

About the Company

FoundedEmployeesCEOWebsite
20149,753Shoji Miyazakihttps://www.phchd.com/jp

PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devices, as well as data linkage solutions; anatomical pathology solutions, such as instruments, microscope slides, and dyeing reagents; and equipment and services for various sample preservation and cell culture in the life sciences field. It also provides healthcare IT products in the field of medical information systems for clinics and healthcare insurance pharmacies.

PHC Holdings Fundamentals Summary

How do PHC Holdings's earnings and revenue compare to its market cap?
6523 fundamental statistics
Market CapJP¥157.26b
Earnings (TTM)-JP¥8.46b
Revenue (TTM)JP¥340.45b

0.5x

P/S Ratio

-18.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
6523 income statement (TTM)
RevenueJP¥340.45b
Cost of RevenueJP¥175.21b
Gross ProfitJP¥165.24b
Other ExpensesJP¥173.70b
Earnings-JP¥8.46b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Aug 10, 2022

Earnings per share (EPS)-68.00
Gross Margin48.53%
Net Profit Margin-2.48%
Debt/Equity Ratio227.7%

How did 6523 perform over the long term?

See historical performance and comparison

Dividends

5.7%

Current Dividend Yield

-54%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is 6523 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6523?

Other financial metrics that can be useful for relative valuation.

6523 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.1x
Enterprise Value/EBITDA9.3x
PEG Ration/a

Price to Sales Ratio vs Peers

How does 6523's PS Ratio compare to its peers?

6523 PS Ratio vs Peers
The above table shows the PS ratio for 6523 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average2x
7716 Nakanishi
4.5x7.9%JP¥203.7b
7817 Paramount Bed Holdings
1.4x4.2%JP¥129.3b
6960 Fukuda Denshi
0.8x0.3%JP¥111.2b
6849 Nihon Kohden
1.1x2.6%JP¥233.2b
6523 PHC Holdings
0.5x1.0%JP¥157.3b

Price-To-Sales vs Peers: 6523 is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (2x).


Price to Earnings Ratio vs Industry

How does 6523's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

Price-To-Sales vs Industry: 6523 is good value based on its Price-To-Sales Ratio (0.5x) compared to the JP Medical Equipment industry average (1.6x)


Price to Sales Ratio vs Fair Ratio

What is 6523's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6523 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.5x
Fair PS Ratio1.6x

Price-To-Sales vs Fair Ratio: 6523 is good value based on its Price-To-Sales Ratio (0.5x) compared to the estimated Fair Price-To-Sales Ratio (1.6x).


Share Price vs Fair Value

What is the Fair Price of 6523 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6523 (¥1264) is trading below our estimate of fair value (¥4294.98)

Significantly Below Fair Value: 6523 is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 6523's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is PHC Holdings forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


36.6%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6523 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.04%).

Earnings vs Market: 6523 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 6523 is expected to become profitable in the next 3 years.

Revenue vs Market: 6523's revenue (1% per year) is forecast to grow slower than the JP market (4.5% per year).

High Growth Revenue: 6523's revenue (1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 6523's Return on Equity is forecast to be low in 3 years time (14.5%).


Discover growth companies

Past Performance

How has PHC Holdings performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-150.0%

Last years earnings growth

Earnings and Revenue History

Quality Earnings: 6523 is currently unprofitable.

Growing Profit Margin: 6523 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if 6523's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare 6523's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 6523 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (14.9%).


Return on Equity

High ROE: 6523 has a negative Return on Equity (-6.1%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is PHC Holdings's financial position?

Financial Health Score

1/6

Financial Health Score 1/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 6523's short term assets (¥216.4B) exceed its short term liabilities (¥137.7B).

Long Term Liabilities: 6523's short term assets (¥216.4B) do not cover its long term liabilities (¥317.5B).


Debt to Equity History and Analysis

Debt Level: 6523's net debt to equity ratio (156%) is considered high.

Reducing Debt: Insufficient data to determine if 6523's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 6523's debt is not well covered by operating cash flow (16.5%).

Interest Coverage: 6523's interest payments on its debt are not well covered by EBIT (1.6x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is PHC Holdings's current dividend yield, its reliability and sustainability?

Dividend Score

2/6

Dividend Score 2/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


5.70%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 6523's dividend (5.7%) is higher than the bottom 25% of dividend payers in the JP market (1.69%).

High Dividend: 6523's dividend (5.7%) is in the top 25% of dividend payers in the JP market (3.74%)


Stability and Growth of Payments

Stable Dividend: Too early to tell whether 6523's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if 6523's dividend payments are increasing as they only just started paying a dividend.


Earnings Payout to Shareholders

Earnings Coverage: 6523 is paying a dividend but the company is unprofitable.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (22.8%), 6523's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

0.2yrs

Average management tenure


CEO

Shoji Miyazaki

0.25

Tenure

Mr. Shoji Miyazaki serves as Chief Executive Officer at PHC Holdings Corporation since April 28, 2022 and serves as its Representative Director and also serves as its President since 2022. He has been Exec...


Leadership Team

Experienced Management: 6523's management team is not considered experienced ( 0.2 years average tenure), which suggests a new team.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: 6523 only recently listed within the past 12 months.


Top Shareholders

Company Information

PHC Holdings Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: PHC Holdings Corporation
  • Ticker: 6523
  • Exchange: TSE
  • Founded: 2014
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: JP¥157.256b
  • Shares outstanding: 124.41m
  • Website: https://www.phchd.com/jp

Number of Employees


Location

  • PHC Holdings Corporation
  • 2-38-5
  • Nishinihonbashi
  • Tokyo
  • 105-8433
  • Japan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/07/02 00:00
End of Day Share Price2022/07/01 00:00
Earnings2022/03/31
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.